Latest news from the FASST trial
The purpose of this study is to evaluate the effectiveness and safety of IVA337 for the treatment of Diffuse Cutaneous Systemic Sclerosis.
Read latest newsletter on the research: FASST Newsletter, May2016
news & events
Article by doctor Susana Oliveira, graduated Hospital Assistant and Systemic Sclerosis Consulting Coordinator at the Professor Doutor Fernando Fonseca Hospital
Artikel von Maria José Guimarães, Pulmonologin, Koordinatorin des pneumologischen Dienstes des Krankenhauses von Luz-Guimarães.
Opinion article by Dr. Maria José Guimarães, Pulmonologist, Coordinator of the Pneumology Service of the Luz-Guimarães Hospital